What is Vertex Pharmaceuticals's equity securities downward price adjustment?

Vertex Pharmaceuticals (VRTX) reported equity securities downward price adjustment of $13.30M in Q3 2024.

What does equity securities downward price adjustment mean?

Reductions in the book value of private or illiquid equity investments.

StatementIncome Statement

SectionOther Income & Expense

CategoryRisk

SignalLower is better

VolatilityModerate

First reportedQ1 2018

Last reportedQ3 2025

An increase in downward adjustments signals potential impairment or poor performance of private equity holdings.

Reflects specific downward valuation adjustments applied to equity securities that lack a readily determinable fair mark...

Common for firms with venture capital or strategic investment arms.

Metric ID: is_jpm_equity_securities_downward_price_adjustment

1 periods

	Q3 '24
Value	$13.30M

What is Vertex Pharmaceuticals's equity securities downward price adjustment?: Vertex Pharmaceuticals (VRTX) reported equity securities downward price adjustment of $13.30M in Q3 2024.
What does equity securities downward price adjustment mean?: Reductions in the book value of private or illiquid equity investments.